Pei S, Zhang D, Li Z, Liu J, Li Z, Chen J
Int J Mol Sci. 2025; 26(4).
PMID: 40003882
PMC: 11855465.
DOI: 10.3390/ijms26041415.
Kumarasamy V, Wang J, Roti M, Wan Y, Dommer A, Rosenheck H
Nat Commun. 2025; 16(1):1476.
PMID: 39924553
PMC: 11808123.
DOI: 10.1038/s41467-025-56674-4.
Mahajan K, Das A, Alahari S, Pothuraju R, Nair S
Cancers (Basel). 2024; 16(17).
PMID: 39272919
PMC: 11394065.
DOI: 10.3390/cancers16173061.
Galan-Vidal J, Garcia-Gaipo L, Molinuevo R, Dias S, Tsoi A, Gomez-Roman J
Cell Death Dis. 2024; 15(8):596.
PMID: 39152119
PMC: 11329632.
DOI: 10.1038/s41419-024-06969-z.
Dong Q, Wang D, Song C, Gong C, Liu Y, Zhou X
Cell Death Differ. 2024; 31(10):1285-1301.
PMID: 39060421
PMC: 11445503.
DOI: 10.1038/s41418-024-01339-w.
Bromodomain protein BRD4 directs mitotic cell division of mouse fibroblasts by inhibiting DNA damage.
Wu T, Hou H, Dey A, Bachu M, Chen X, Wisniewski J
iScience. 2024; 27(7):109797.
PMID: 38993671
PMC: 11237862.
DOI: 10.1016/j.isci.2024.109797.
Identification of molecular subtypes and a prognostic signature based on m6A/m5C/m1A-related genes in lung adenocarcinoma.
Zhang Y, Jia Q, Li F, Luo X, Wang Z, Wang X
Sci Rep. 2024; 14(1):7543.
PMID: 38555384
PMC: 10981664.
DOI: 10.1038/s41598-024-57910-5.
Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactions.
Zhu Y, Tang S, Yuan Q, Fu J, He J, Liu Z
Cell Rep Med. 2024; 5(2):101375.
PMID: 38278146
PMC: 10897507.
DOI: 10.1016/j.xcrm.2023.101375.
HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2.
Jiang J, Zhu J, Qiu P, Ni J, Zhu W, Wang X
Funct Integr Genomics. 2023; 24(1):3.
PMID: 38091112
DOI: 10.1007/s10142-023-01279-7.
FOXM1 is critical for the fitness recovery of chromosomally unstable cells.
Pan F, Chocarro S, Ramos M, Chen Y, Alonso de la Vega A, Somogyi K
Cell Death Dis. 2023; 14(7):430.
PMID: 37452072
PMC: 10349069.
DOI: 10.1038/s41419-023-05946-2.
Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer.
Katzenellenbogen B, Guillen V, Katzenellenbogen J
Breast Cancer Res. 2023; 25(1):76.
PMID: 37370117
PMC: 10304361.
DOI: 10.1186/s13058-023-01675-8.
Increased FOXM1 Expression was Associated with the Prognosis and the Recruitment of Neutrophils in Endometrial Cancer.
Chen J, Yang P, Li S, Feng Y
J Immunol Res. 2023; 2023:5437526.
PMID: 37159818
PMC: 10163965.
DOI: 10.1155/2023/5437526.
Copper overload impairs hematopoietic stem and progenitor cell proliferation prompting HSF1/SP1 aggregation and the subsequently downregulating axis.
Li L, Tai Z, Liu W, Luo Y, Wu Y, Lin S
iScience. 2023; 26(4):106406.
PMID: 37009226
PMC: 10050659.
DOI: 10.1016/j.isci.2023.106406.
A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle.
Li H, Dong L, Jin M, Li Q, Wang X, Jia M
Molecules. 2023; 28(3).
PMID: 36770809
PMC: 9920120.
DOI: 10.3390/molecules28031141.
PVECs-Derived Exosomal microRNAs Regulate PASMCs via FoxM1 Signaling in IUGR-induced Pulmonary Hypertension.
Luo X, Hang C, Zhang Z, Le K, Ying Y, Lv Y
J Am Heart Assoc. 2022; 11(24):e027177.
PMID: 36533591
PMC: 9798821.
DOI: 10.1161/JAHA.122.027177.
Ethnic and racial-specific differences in levels of centrosome-associated mitotic kinases, proliferative and epithelial-to-mesenchymal markers in breast cancers.
Rivera-Rivera Y, Vargas G, Jaiswal N, Nunez-Marrero A, Li J, Chen D
Cell Div. 2022; 17(1):6.
PMID: 36494865
PMC: 9733043.
DOI: 10.1186/s13008-022-00082-3.
Generation and multiomic profiling of a double-knockout gastroesophageal junction organoid model.
Zhao H, Cheng Y, Kalra A, Ma K, Zheng Y, Ziman B
Sci Transl Med. 2022; 14(673):eabq6146.
PMID: 36449602
PMC: 10026384.
DOI: 10.1126/scitranslmed.abq6146.
FOXM1 Inhibition Enhances the Therapeutic Outcome of Lung Cancer Immunotherapy by Modulating PD-L1 Expression and Cell Proliferation.
Madhi H, Lee J, Choi Y, Li Y, Kim M, Choi Y
Adv Sci (Weinh). 2022; 9(29):e2202702.
PMID: 35975458
PMC: 9561767.
DOI: 10.1002/advs.202202702.
CDI Exerts Anti-Tumor Effects by Blocking the FoxM1-DNA Interaction.
Jang W, Lee M, Mun J, Lim G, Oh K
Biomedicines. 2022; 10(7).
PMID: 35884976
PMC: 9313426.
DOI: 10.3390/biomedicines10071671.
POLE2 facilitates the malignant phenotypes of glioblastoma through promoting AURKA-mediated stabilization of FOXM1.
Zhang P, Chen X, Zhang L, Cao D, Chen Y, Guo Z
Cell Death Dis. 2022; 13(1):61.
PMID: 35039475
PMC: 8763902.
DOI: 10.1038/s41419-021-04498-7.
